Complicated Appendicitis
14
2
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
7.1%
1 terminated out of 14 trials
90.0%
+3.5% vs benchmark
43%
6 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (14)
Oral Lactulose for Gastrointestinal Recovery After Complex Appendectomy
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Antibiotic Instillation in Appendicitis
Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis
Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.
Antibiotic Duration in Post-appendectomy Abscess
ERAS for Pediatric Acute Appendicitis
Optimal Care of Complicated Appendicitis
New Diagnostic Markers In Dignosis Of Complicated Appendix
Complicated Appendicitis During the COVID-19 Pandemic in Jordan
Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
Complicated Appendicitis in COVID-19 Era
Causes of Complicated Appendicitis at Referral Hospital
Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children